Evidence map›Paper›PMID 38490717›Full record

ArticleLife science alliance2024

CRL4

Josina Grossmann, Anne-Sophie Kratz, Alina Kordonsky, Gali Prag, Ingrid Hoffmann

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Josina GrossmannCell Cycle Control and Carcinogenesis, German Cancer Research Center, DKFZ, Heidelberg, Germany.
Anne-Sophie KratzCell Cycle Control and Carcinogenesis, German Cancer Research Center, DKFZ, Heidelberg, Germany.
Alina KordonskySchool of Neurobiology, Biochemistry and Biophysics, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Gali PragSchool of Neurobiology, Biochemistry and Biophysics, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0003-4703-7161
Ingrid HoffmannCell Cycle Control and Carcinogenesis, German Cancer Research Center, DKFZ, Heidelberg, Germany ingrid.hoffmann@dkfz.de.ORCID 0000-0002-8894-8597
German Cancer Research Center · DETel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Centrioles play important roles in the assembly of centrosomes and cilia. Centriole duplication occurs once per cell cycle and is dependent on polo-like kinase 4 (PLK4). To prevent centriole amplification, which is a hallmark of cancer, PLK4 protein levels need to be tightly regulated. Here, we show that the Cullin4A/B-DDB1-DCAF1, CRL4

Indexed as

CentriolesUbiquitinbeta-Transducin Repeat-Containing ProteinsCell CycleHumansProtein Serine-Threonine KinasesUbiquitin-Protein Ligasesbeta-Transducin Repeat-Containing ProteinsPLK4 protein, humanProtein Serine-Threonine KinasesUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID38490717
PMCPMC10942865
OpenAlexW4392846332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.